We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Junk DNA May Act as a Molecular Bridge

By Biotechdaily staff writers
Posted on 10 Sep 2002
Researchers have identified a cohesin-containing protein complex that reshapes chromatin to allow cohesins to bind to the repetitive Alu DNA sequences, areas of the genome not known to directly control genetic activity and sometimes referred to as junk DNA. More...
Their finding was reported in the August 29, 2002, issue of Nature.

The investigators found that when the chromatin's histone proteins were methylated and acetylated, the chromatin structure relaxed to allow access to the DNA. However, if the Alu sequence on the DNA was itself methylated, then the cohesin could not bind to the DNA at that site.

"One thing that interested us is that there are 500,000-1,000,000 Alu repeats across the human genome,” explained Dr. Ramin Shiekhattar, an associate professor at The Wistar Institute (Philadelphia, PA, USA; www.wistar.upenn.edu) and the study's senior author. "These sequences are very common. And this makes sense if one of their roles is to bind to the bridging proteins, the cohesins, to keep the replicated DNA sisters together until it is time for them to separate. Multiple bridging sites throughout the DNA would be needed for this system to work. They could not be unique sequences.”

"The idea that a kind of code of modifications to the molecular packaging of DNA may govern gene activity is an intriguing one, said Dr. Shiekhattar. "If we were to better understand this code, it might provide us with important insights into diseases tied to problems in gene control, including developmental disorders and cancer.”



Related Links:
The Wistar Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.